US faces 'new normal' of slower research pace under sequester
This article was originally published in Scrip
The $1.5 billion the National Institutes of Health (NIH) lost from its fiscal year 2013 budget because of the across-the-board sequestration spending cuts that took effect on 27 March could become "the new normal" for the agency for at least the next decade, unless something is done to stop that budget-slashing bulldozer, said Senator Barbara Mikulski (Democrat-Maryland).
You may also be interested in...
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.